Elucidata offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolic disorders. Elucidata supports discovery programs at Pfizer, Agios Pharmaceuticals, Gene... Read more